Growth Metrics

Omeros (OMER) Assets (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -12.12%
Dec 31, 2025 75.35%
Sep 30, 2025 -7.41%
Jun 30, 2025 -14.71%
Mar 31, 2025 -15.13%
Dec 31, 2024 -11.57%
Sep 30, 2024 -12.06%
Jun 30, 2024 -18.56%
Mar 31, 2024 15.66%
Dec 31, 2023 -23.28%
Sep 30, 2023 -6.51%
Jun 30, 2023 -5.84%
Mar 31, 2023 -5.22%
Dec 31, 2022 29.16%
Sep 30, 2022 32.38%
Jun 30, 2022 -6.40%
Mar 31, 2022 -11.93%
Dec 31, 2021 239.68%
Sep 30, 2021 -15.10%
Jun 30, 2021 -9.94%
Mar 31, 2021 -10.83%
Dec 31, 2020 -20.27%
Sep 30, 2020 221.23%
Jun 30, 2020 -40.20%
Mar 31, 2020 -13.69%
Dec 31, 2019 50.08%
Sep 30, 2019 1.67%
Jun 30, 2019 -11.34%
Mar 31, 2019 5.53%
Dec 31, 2018 26.88%
Sep 30, 2018 -28.90%
Jun 30, 2018 19.45%
Mar 31, 2018 -23.46%
Dec 31, 2017 -7.32%
Sep 30, 2017 107.97%
Jun 30, 2017 3.34%
Mar 31, 2017 -13.19%
Dec 31, 2016 -7.54%
Sep 30, 2016 57.81%
Jun 30, 2016 28.18%
Mar 31, 2016 -26.58%
Dec 31, 2015 18.30%
Sep 30, 2015 -29.37%
Jun 30, 2015 -21.72%
Mar 31, 2015 591.44%
Dec 31, 2014 -57.17%
Sep 30, 2014 -38.30%
Jun 30, 2014 -26.89%
Mar 31, 2014 239.08%
Dec 31, 2013 37.63%
Sep 30, 2013 -47.90%
Jun 30, 2013 30.32%
Mar 31, 2013 -33.42%
Dec 31, 2012 -18.88%
Sep 30, 2012 225.46%
Jun 30, 2012 -52.27%
Mar 31, 2012 -21.84%
Dec 31, 2011 -22.87%
Sep 30, 2011 -14.56%